DOCSLIB.ORG

Zika Virus M Protein As a Viroporin Drug Target

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Zika Virus M Protein As a Viroporin Drug Target Zika virus M protein as a viroporin drug target Emma Tabitha Brown Submitted in accordance with the requirements for the degree of Doctor of Philosophy The University of Leeds Faculty of Medicine and Health August 2020 The candidate confirms that the work submitted is their own and that appropriate credit has been given where reference has been made to the work of others. Chapter 4 Figure 4.4 Grids stained by myself and transmission electron microscopy (TEM) images generated by Dr Daniel Maskell and Dr Rebecca Thompson Figure 4.6 Images taken by Dr Daniel Maskell and Dr Rebecca Thompson, processing carried out by myself. Figure 4.17 In vivo assay carried out by Dr Daniella Lefteri and Dr Clive McKimmie, sample processing carried out by myself. Chapter 5 Figure 5.3 Identification of binding sites carried out by Dr Ravi Singh, Dr Stephen Griffin and by myself. Figure 5.4 Docking and images generated by Dr Ravi Singh using PyMOL and Maestro Table 5.2 & 5.3 High-throughput screen carried out by Ravi Singh using Maestro Figure 5.7- 5.12 Maestro interaction images generated by Dr Ravi Singh i Acknowledgements Thank you to my supervisor Dr Stephen Griffin for all his support throughout my PhD, encouraging and believing in me. Thank you to my co-supervisor Dr Antreas Kalli for joining my supervisory team, your MD training and endlessly answering my questions. I would also like to thank co-supervisors Dr Clive McKimmie and Dr Richard Foster for your support. Thank you to Dr Ravi Singh for your help using the modelling software and carrying out the in silico docking. Thank you to Dr Daniella Lefteri for carrying out the in vivo work. Thank you to Dr Daniel Maskell and Dr Rebecca Thompson for providing the TEM images. Thank you to Griffin group members Dr Matthew Bentham, Dr Abigail Bloy and Hannah Beaumont for your technical help throughout my first couple of months, answering my questions and ongoing moral support with lots of cups of tea and cake. Thank you also to newer group member Alex Kilvington, I wish you the best of luck in the future. Thank you to all the lovely people on level 5 who made my time enjoyable with endless support and baked goods! Thank you to Hyde Park Harriers for encouraging me to get out running on an evening and weekends, but most importantly for the amazing friendships and memories. I would like to thank all my friends and family for the support over the years. A special thank you to my parents Sally and Mick for your support and encouragement throughout my higher education. Last but not least, thank you to Brad for being understanding, cheering me up and ensuring that, outside of the lab and writing I got out for plenty of climbing adventures. ii Abstract Zika virus (ZIKV) an arbovirus that became widely known in 2015 due to the epidemic in Brazil, spreading across South and North America. Whilst previous Old World ZIKV outbreaks comprised largely mild, or even asymptomatic infections, the New World epidemic became notorious for its association with foetal microcephaly following maternal infection, and an increased incidence of various neurological symptoms, including Guillain-Barré syndrome. Mature, infectious ZIKV particles comprise three structural proteins, Capsid (C), small Membrane (M) and the envelope (E) glycoprotein; the latter is responsible for receptor binding and mediates membrane fusion upon encountering low pH within the acidifying endosome. However, the function of M within this context is unknown. Based upon its structural similarity to “viroporins”, a class of virus-coded ion channels mediating virus entry and uncoating, we investigated whether M could form alternative oligomeric forms to the dimeric structure seen within mature virions, and in so doing exhibit channel activity. Gratifyingly, M peptides adopted higher order structures within membrane-mimetic environments and displayed channel activity in vitro, sensitive to the prototypic viroporin inhibitor, Rimantadine. Accordingly, ZIKV entry was blocked in a dose-dependent fashion by the drug, which also prevented virus spread in mouse models of ZIKV infection. Molecular dynamics simulations supported that M protein is able to oligomerise into a hexameric viroporin channel, opening of which was within acidified environments via protonation of a conserved histidine residue. Rimantadine was predicted in silico to interact at a lumenal binding site, against which we derived improved inhibitors from a library of generic, FDA-approved and other bio-active small molecules, providing a basis for novel M protein targeted drug discovery. Significantly, due to its role during virus entry, M- targeted drugs might either prevent or reduce the severity of ZIKV infections, including those crossing the placenta, and may also show activity against closely related M proteins from other Flaviviruses. iii Table of Contents Acknowledgements ..................................................................................... ii Abstract ....................................................................................................... iii Table of Contents ........................................................................................ iv Table of Figures ........................................................................................ viii Abbreviations ............................................................................................. xii Chapter 1 Introduction ................................................................................ 1 1.1 Flaviviruses ...................................................................................... 1 1.2 Zika virus (ZIKV) ............................................................................... 1 1.2.1 Origin and Discovery ............................................................... 1 1.2.2 Transmission ........................................................................... 2 1.2.3 Symptoms ............................................................................... 5 1.3 Epidemiology .................................................................................... 6 1.4 Molecular biology of Zika virus (ZIKV) ............................................ 11 1.4.1 Zika virus genome structure .................................................. 11 1.4.2 Zika virus structural proteins ................................................. 11 1.4.3 Zika virus Non-structural proteins .......................................... 21 1.5 Zika virus life cycle ......................................................................... 29 1.5.1 Entry ...................................................................................... 29 1.5.2 Translation ............................................................................ 33 1.5.3 Polyprotein processing .......................................................... 34 1.5.4 Virus genome replication ....................................................... 35 1.5.5 Capping ................................................................................. 36 1.5.6 Virus assembly, budding, maturation and release ................. 36 1.6 ZIKV model systems....................................................................... 38 1.7 Vaccines ......................................................................................... 39 1.8 Antivirals and pharmacological disease management .................... 39 1.9 M protein as an antiviral target ....................................................... 41 1.9.1 M protein structure and function ............................................ 41 1.10 Viroporins ....................................................................................... 42 1.10.1 Influenza A Virus (IAV) M2 .................................................... 44 1.10.2 Hepatitis C Virus (HCV) p7.................................................... 46 1.10.3 Human immunodeficiency Virus type-1 (HIV-1) Vpu ............. 48 1.10.4 Human Respiratory Syncytial Virus (hRSV) SH .................... 49 iv 1.10.5 Human Papillomavirus type 16 (HPV-16) E5 ........................ 50 1.10.6 Enterovirus VP4 .................................................................... 51 1.11 Aims ............................................................................................... 52 Chapter 2 Materials and Methods ............................................................. 53 2.1.1 Zika Virus .............................................................................. 53 2.2 Mammalian Cell Culture ................................................................. 53 2.2.1 Recovery of frozen cells ........................................................ 53 2.2.2 Maintenance and Passage of Cells ....................................... 53 2.2.3 Freezing cells ........................................................................ 53 2.2.4 MTT Assay ............................................................................ 54 2.2.5 EGF Uptake Assay ................................................................ 54 2.2.6 Immunofluorescence ............................................................. 54 2.3 Virus production and storage .......................................................... 55 2.3.1 Virus stock propagation ......................................................... 55 2.3.2 Freezing virus ........................................................................ 55 2.3.3 Determination of Virus Titre................................................... 55 2.3.4 Virus assays .........................................................................
Load more

Recommended publications
  • Herpes Simplex Virus Type 1 Oril Is Not Required for Virus Infection In
    JOURNAL OF VIROLOGY, Nov. 1987, p. 3528-3535 Vol. 61, No. 11 0022-538X/87/113528-08$02.00/0 Copyright C 1987, American Society for Microbiology Herpes Simplex Virus Type 1 oriL Is Not Required for Virus Replication or for the Establishment and Reactivation of Latent Infection in Mice MARYELLEN POLVINO-BODNAR, PAULO K. ORBERG, AND PRISCILLA A. SCHAFFER* Laboratory of Tumor Virus Genetics, Dana-Farber Cancer Institute, and Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115 Received 11 May 1987/Accepted 31 July 1987 During the course of experiments designed to isolate deletion mutants of herpes simplex virus type 1 in the gene encoding the major DNA-binding protein, ICP8, a mutant, d61, that grew efficiently in ICP8-expressing Vero cells but not in normal Vero cells was isolated (P. K. Orberg and P. A. Schaffer, J. Virol. 61:1136-1146, 1987). d61 was derived by cotransfection of ICP8-expressing Vero cells with infectious wild-type viral DNA and a plasmid, pDX, that contains an engineered 780-base-pair (bp) deletion in the ICP8 gene, as well as a spontaneous -55-bp deletion in OriL. Gel electrophoresis and Southern blot analysis indicated that d61 DNA carried both deletions present in pDX. The ability of d61 to replicate despite the deletion in OriL suggested that a functional OriL is not essential for virus replication in vitro. Because d61 harbored two mutations, a second mutant, ts+7, with a deletion in oriL-associated sequences and an intact ICP8 gene was constructed. Both d61 and ts+7 replicated efficiently in their respective permissive host cells, although their yields were slightly lower than those of control viruses with intact oriL sequences.
    [Show full text]
  • Foamy Virus Assembly with Emphasis on Pol Encapsidation
    Viruses 2013, 5, 886-900; doi:10.3390/v5030886 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Foamy Virus Assembly with Emphasis on Pol Encapsidation Eun-Gyung Lee 1, Carolyn R. Stenbak 2 and Maxine L. Linial 1,* 1 Fred Hutchinson Cancer Research Center, Basic Sciences Division; 1100 Fairview Avenue North, Seattle, WA 98109, USA; E-Mails: [email protected] (EGL); [email protected] (MLL) 2 Seattle University, Biology Department; 901 12th Avenue, Seattle, WA 98122, USA; E-Mail: [email protected] * Authors to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-206- 667-4442; Fax: +1-206-667-5939 Received: 31 January 2013; in revised form: 11 March 2013 / Accepted: 14 March 2013 / Published: 20 March 2013 Abstract: Foamy viruses (FVs) differ from all other genera of retroviruses (orthoretroviruses) in many aspects of viral replication. In this review, we discuss FV assembly, with special emphasis on Pol incorporation. FV assembly takes place intracellularly, near the pericentriolar region, at a site similar to that used by betaretroviruses. The regions of Gag, Pol and genomic RNA required for viral assembly are described. In contrast to orthoretroviral Pol, which is synthesized as a Gag-Pol fusion protein and packaged through Gag-Gag interactions, FV Pol is synthesized from a spliced mRNA lacking all Gag sequences. Thus, encapsidation of FV Pol requires a different mechanism. We detail how WT Pol lacking Gag sequences is incorporated into virus particles. In addition, a mutant in which Pol is expressed as an orthoretroviral-like Gag-Pol fusion protein is discussed.
    [Show full text]
  • Topological Analysis of the Gp41 MPER on Lipid Bilayers Relevant to the Metastable HIV-1 Envelope Prefusion State
    Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state Yi Wanga,b, Pavanjeet Kaurc,d, Zhen-Yu J. Sune,1, Mostafa A. Elbahnasawya,b,2, Zahra Hayatic,d, Zhi-Song Qiaoa,b,3, Nhat N. Buic, Camila Chilea,b,4, Mahmoud L. Nasre,5, Gerhard Wagnere, Jia-Huai Wanga,f, Likai Songc, Ellis L. Reinherza,b,6, and Mikyung Kima,g,6 aLaboratory of Immunobiology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115; bDepartment of Medicine, Harvard Medical School, Boston, MA 02115; cNational High Magnetic Field Laboratory, Florida State University, Tallahassee, FL 32306; dDepartment of Physics, Florida State University, Tallahassee, FL 32306; eDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115; fDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215; and gDepartment of Dermatology, Harvard Medical School, Boston, MA 02215 Edited by Peter Palese, Icahn School of Medicine at Mount Sinai, New York, NY, and approved September 23, 2019 (received for review July 18, 2019) The membrane proximal external region (MPER) of HIV-1 envelope immunologically vulnerable epitopes targeted by several of the most glycoprotein (gp) 41 is an attractive vaccine target for elicitation of broadly neutralizing antibodies (bNAbs) developed during the broadly neutralizing antibodies (bNAbs) by vaccination. However, course of natural HIV-1 infection (10–13). Insertion, deletion, current details regarding the quaternary structural organization of and mutations of residues in the MPER defined the functional the MPER within the native prefusion trimer [(gp120/41)3] are elu- importance of the MPER in Env incorporation, viral fusion, and sive and even contradictory, hindering rational MPER immunogen infectivity (14–16).
    [Show full text]
  • (Infected Cell Protein 8) of Herpes Simplex Virus L*
    THEJOURNAL OF BIOLOGICAL CHEMISTRY Vol. 262, No. 9, Issue of March 25, pp. 4260-4266, 1987 0 1987 by The American Society of Biological Chemists, Inc Printed in U.S. A. Interaction between theDNA Polymerase and Single-stranded DNA- binding Protein (Infected Cell Protein 8) of Herpes Simplex Virus l* (Received for publication, September 22, 1986) Michael E. O’DonnellS, Per EliasQ,Barbara E. Funnellll, and I. R. Lehman From the Department of Biochemistry, Stanford University School of Medicine, Stanford, California 94305 The herpes virus-encoded DNA replication protein, ICP8 completely inhibits replication of singly primed ssDNA infected cell protein 8 (ICPS), binds specifically to templates by the herpespolymerase. On the other hand, ICP8 single-stranded DNA with a stoichiometry of one ICPS strongly stimulates replication of duplex DNA. It does so, molecule/l2 nucleotides. In the absence of single- however, onlyin the presence of anuclear extract from stranded DNA, it assembles into long filamentous herpes-infected cells. structures. Binding of ICPS inhibits DNA synthesis by the herpes-induced DNA polymerase on singly primed EXPERIMENTALPROCEDURES single-stranded DNA circles. In contrast, ICPS greatly Materials-DNase I and venom phosphodiesterase were obtained stimulates replication of circular duplex DNA by the from Worthington. The syntheticoligodeoxynucleotide (44-mer) was polymerase. Stimulation occurs only in the presence of synthesized by the solid-phase coupling of protected phosphoramidate a nuclear extract from herpes-infected cells. Appear- nucleoside derivatives (11).3H-Labeled #X ssDNA was a gift from ance of the stimulatory activity in nuclear extracts Dr. R. Bryant (this department). pMOB45 (10.5 kilobases) linear coincides closely with the time of appearance of her- duplex plasmid DNA was a gift from Dr.
    [Show full text]
  • Progressive Multifocal Leukoencephalopathy and the Spectrum of JC Virus-​Related Disease
    REVIEWS Progressive multifocal leukoencephalopathy and the spectrum of JC virus- related disease Irene Cortese 1 ✉ , Daniel S. Reich 2 and Avindra Nath3 Abstract | Progressive multifocal leukoencephalopathy (PML) is a devastating CNS infection caused by JC virus (JCV), a polyomavirus that commonly establishes persistent, asymptomatic infection in the general population. Emerging evidence that PML can be ameliorated with novel immunotherapeutic approaches calls for reassessment of PML pathophysiology and clinical course. PML results from JCV reactivation in the setting of impaired cellular immunity, and no antiviral therapies are available, so survival depends on reversal of the underlying immunosuppression. Antiretroviral therapies greatly reduce the risk of HIV-related PML, but many modern treatments for cancers, organ transplantation and chronic inflammatory disease cause immunosuppression that can be difficult to reverse. These treatments — most notably natalizumab for multiple sclerosis — have led to a surge of iatrogenic PML. The spectrum of presentations of JCV- related disease has evolved over time and may challenge current diagnostic criteria. Immunotherapeutic interventions, such as use of checkpoint inhibitors and adoptive T cell transfer, have shown promise but caution is needed in the management of immune reconstitution inflammatory syndrome, an exuberant immune response that can contribute to morbidity and death. Many people who survive PML are left with neurological sequelae and some with persistent, low-level viral replication in the CNS. As the number of people who survive PML increases, this lack of viral clearance could create challenges in the subsequent management of some underlying diseases. Progressive multifocal leukoencephalopathy (PML) is for multiple sclerosis. Taken together, HIV, lymphopro- a rare, debilitating and often fatal disease of the CNS liferative disease and multiple sclerosis account for the caused by JC virus (JCV).
    [Show full text]
  • Enzyme Activities in Four Different Forms of Human Immunodeficiency
    Proc. Nati. Acad. Sci. USA Vol. 88, pp. 45%-4600, June 1991 Biochemistry Enzyme activities in four different forms of human immunodeficiency virus 1 poi gene products (reverse transcriptase/RNase H/crossover linker mutagenesis/baculoirus expression system) YU-WEN HU AND C. YONG KANG Department of Microbiology and Immunology, University of Ottawa, Faculty of Medicine, Ottawa, ON, Canada K1H 8M5 Communicated by Max D. Summers, February 19, 1991 (received for review December 3, 1990) ABSTRACT Five cassettes of the pol gene of human im- activity (10, 11) but no RNase H activity (3, 7, 12, 13). The munodeficiency virus 1 were constructed and inserted under reverse transcriptase isolated from purified HIV-1 has a the control of the polyhedrin gene promoter of Autographa molecular mass of 95 (14) to 110 (15) kDa, as determined by calfornica nuclear polyhedrosis virus by homologous recom- gel filtration and glycerol gradient centrifugation, respec- bination. The first cassette polF contains the full-length pol tively. However, the 98-kDa nonprocessed polyprotein ex- open reading frame; the second cassette pollOO starts with the pressed in Escherichia coli displayed little or no reverse first AUG codon of the pol gene and deletes 103 amino acids transcriptase activity (16). The p66/pSi heterodimer ex- from the amino terminus of the pol gene product; the third pressed in E. coli has an apparent molecular mass of 120-130 cassette po197 deletes the entire protease coding sequence; the kDa and was active (5, 6). In addition, there is a 165-kDa fourth cassette po166 deletes both the protease and endonucle- putative gag-pol precursor polyprotein that also possesses ase/integrase coding sequences; and the fifth cassette polSl reverse transcriptase activity (10).
    [Show full text]
  • Investigation of Proton Conductance in the Matrix 2 Protein of the Influenza Virus by Solution NMR Spectroscopy © Daniel Turman
    Investigation of proton conductance in the matrix 2 protein of the influenza virus by solution NMR spectroscopy © Daniel Turman Emmanuel College Class 0[2012 Abstract The Influenza Matrix 2 (M2) protein is a homo-tetrameric integral membrane protein that forms a proton selective transmembrane channell Its recognized function is to equilibrate pH across the viral envelope following endocytosis and across the trans-golgi membrane during viral maturation2 Its function is vital for viral infection and proliferation but the mechanism and selectivity of proton conductance is not well understood. Mutagenesis studies have identified histidine 37 as the pH sensing element and tryptophan 41 as the gating selectivity filter3 This study uses solution nuclear magnetic resonance spectroscopy and an M2 transmembrane protein construct to elucidate key interactions between the aromatic residues believed to confer proton selectivity and pH dependent conduction of M2 in the low pH open and high pH closed states. PH dependent 13 C_1 H HSQC-Trosy experiments were completed in the pH range of 8.0 - 4.0 and the 13 C, and 13 Co2 chemical shift perturbations of histidine 37 revealed multiple saturation points. The protonation states of histidine 37 suggest a shuttling mechanism for proton conduction. Introduction Influenza is a pathogenic virus that has reached pandemic status four times in the twentieth century. The latest pandemic occurred in 2009 from the influenza A HINI strain (figure 1t The World Health Organization (WHO) commented in July of 2009, "this outbreak is unstoppable." Following this event, significant research has been allocated to understand all aspects of the influenza virus in an effort to produce effective vaccines and medications to prevent and control another pandemic.
    [Show full text]
  • Genomic Diversity in Rotavirus and the Current Scenario of Rotavirus Vaccines: a Brief Overview
    Central Archives of Paediatrics and Developmental Pathology Bringing Excellence in Open Access Review Article *Corresponding author Vijaya Lakshmi Nag, Department of Microbiology, All India Institute of Medical Sciences, Jodhpur, India, Tel: Genomic Diversity in Rotavirus 918003996874; Email: Submitted: 15 October 2017 and the Current Scenario of Accepted: 01 November 2017 Published: 03 November 2017 Copyright Rotavirus Vaccines: A Brief © 2017 Nag et al. Overview OPEN ACCESS Keywords Vijaya Lakshmi Nag* and Kumar Saurabh • Rotavirus infection Department of Microbiology, All India Institute of Medical Sciences, India • Genomic diversity • Rotavirus vaccines Abstract Rotavirus associated infection still dominates the list of diarrheal illnesses in paediatric population despite the availability of effective Rotavirus vaccines. Frequent genetic reassortment in the genome of rotavirus leads to emergence of novel genotypes in different geographic areas worldwide. This review aims to give a brief overview of the genetic diversity prevailing in rotavirus worldwide with a focus on the vaccines available for rotavirus infection. ABBREVIATIONS may also be used. Electron microscopy and polyacrylamide gel electrophoresis are also useful. Molecular techniques like nested RV: Rotavirus Infection; RNA: Ribonucleic Acid; EIA: polymerase chain reaction (PCR), multiplex PCR and Reverse Enzyme Immunoassay; ELISA: Enzyme Linked Immunosorbent transcriptase PCR (RT-PCR) in stool samples can additionally Assay; IgA: Immunoglobulin A; IgG: Immunoglobulin G; PCR: help in the genotypic studies [5-7]. The genetic sequencing Polymerase Chain Reaction; RT-PCR: Reverse Transcriptase PCR; methods like microarray and real time PCR (RT-qPCR) are very VP: Viral Structural Protein; NSP: Non-Structural Protein; PAGE: sensitive methods for diagnosis [8]. Polyacrylamide Gel Electrophoresis; RRV: Rhesus Rotavirus, UIP: Universal Immunization Programme; WHO: World Health Vaccine development and implementation has seen lots of Organization.
    [Show full text]
  • Lentivirus and Lentiviral Vectors Fact Sheet
    Lentivirus and Lentiviral Vectors Family: Retroviridae Genus: Lentivirus Enveloped Size: ~ 80 - 120 nm in diameter Genome: Two copies of positive-sense ssRNA inside a conical capsid Risk Group: 2 Lentivirus Characteristics Lentivirus (lente-, latin for “slow”) is a group of retroviruses characterized for a long incubation period. They are classified into five serogroups according to the vertebrate hosts they infect: bovine, equine, feline, ovine/caprine and primate. Some examples of lentiviruses are Human (HIV), Simian (SIV) and Feline (FIV) Immunodeficiency Viruses. Lentiviruses can deliver large amounts of genetic information into the DNA of host cells and can integrate in both dividing and non- dividing cells. The viral genome is passed onto daughter cells during division, making it one of the most efficient gene delivery vectors. Most lentiviral vectors are based on the Human Immunodeficiency Virus (HIV), which will be used as a model of lentiviral vector in this fact sheet. Structure of the HIV Virus The structure of HIV is different from that of other retroviruses. HIV is roughly spherical with a diameter of ~120 nm. HIV is composed of two copies of positive ssRNA that code for nine genes enclosed by a conical capsid containing 2,000 copies of the p24 protein. The ssRNA is tightly bound to nucleocapsid proteins, p7, and enzymes needed for the development of the virion: reverse transcriptase (RT), proteases (PR), ribonuclease and integrase (IN). A matrix composed of p17 surrounds the capsid ensuring the integrity of the virion. This, in turn, is surrounded by an envelope composed of two layers of phospholipids taken from the membrane of a human cell when a newly formed virus particle buds from the cell.
    [Show full text]
  • Respiratory Syncytial Virus and Coronaviruses
    Chapter 3 Structural and Functional Aspects of Viroporins in Human Respiratory Viruses: Respiratory Syncytial Virus and Coronaviruses Wahyu Surya, Montserrat Samsó and Jaume Torres Additional information is available at the end of the chapter http://dx.doi.org/10.5772/53957 1. Introduction Viroporins are an increasingly recognized class of small viral membrane proteins (~60-120 amino acids) which oligomerize to produce hydrophilic pores at the membranes of virus- infected cells [1]. The existence of ‘viroporins’ was proposed more than 30 years ago after observing enhanced membrane permeability in infected cells [2]. These proteins form oligomers of defined size, and can act as proton or ion channels, and in general enhancing membrane permeability in the host [3]. Even though viroporins are not essential for the rep‐ lication of viruses, their absence results in attenuated or weakened viruses or changes in tropism (organ localization) and therefore diminished pathological effects [4, 5]. In addition to having one – sometimes two – α-helical transmembrane (TM) domain(s), viro‐ porins usually contain additional extramembrane regions that are able to make contacts with viral or host proteins. Indeed, the network of interactions of viroporins with other viral or cellular proteins is key to understand the regulation of viral protein trafficking through the vesicle system, viral morphogenesis and pathogenicity. In general, viroporins participate in the entry or release of viral particles into or out of cells, and membrane permeabilization may be a desirable functionality for the virus. Indeed, sev‐ eral viral proteins that are not viroporins are known to affect membrane permeabilization, e.g., A38L protein of vaccinia virus, a 33-kDa glycoprotein that allows Ca2+ influx and indu‐ ces necrosis in infected cells [6].
    [Show full text]
  • Vpr Mediates Immune Evasion and HIV-1 Spread by David R. Collins A
    Vpr mediates immune evasion and HIV-1 spread by David R. Collins A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Microbiology and Immunology) in the University of Michigan 2015 Doctoral Committee: Professor Kathleen L. Collins, Chair Professor David M. Markovitz Associate Professor Akira Ono Professor Alice Telesnitsky © David R. Collins ________________________________ All Rights Reserved 2015 Dedication In loving memory of Sullivan James and Aiko Rin ii Acknowledgements I am very grateful to my mentor, Dr. Kathleen L. Collins, for providing excellent scientific training and guidance and for directing very exciting and important research. I am in the debt of my fellow Collins laboratory members, present and former, for their daily support, encouragement and assistance. In particular, I am thankful to Dr. Michael Mashiba for pioneering our laboratory’s investigation of Vpr, which laid the framework for this dissertation, and for key contributions to Chapter II and Appendix. I am grateful to Jay Lubow and Dr. Zana Lukic for their collaboration and contributions to ongoing work related to this dissertation. I also thank the members of my thesis committee, Dr. Akira Ono, Dr. Alice Telesnitsky, and Dr. David Markovitz for their scientific and professional guidance. Finally, this work would not have been possible without the unwavering love and support of my family, especially my wife Kali and our wonderful feline companions Ayumi, Sully and Aiko, for whom I continue to endure life’s
    [Show full text]
  • The Expression and Distribution of Insertionally Polymorphic Endogenous Retroviruses in Canine Cancer Derived Cell Lines
    THE EXPRESSION AND DISTRIBUTION OF INSERTIONALLY POLYMORPHIC ENDOGENOUS RETROVIRUSES IN CANINE CANCER DERIVED CELL LINES. Abigail S. Jarosz A Thesis Submitted to the Graduate College of Bowling Green State University in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE August 2018 Committee: Julia Halo-Wildschutte, Advisor Raymond Larsen Zhaohui Xu © 2018 Abigail S. Jarosz All Rights Reserved iii ABSTRACT Julia Halo-Wildschutte, Advisor To our knowledge there are no current infectious retroviruses found in canines or wild canids. It has been previously thought that the canine reference genome consists only of about 0.15% of sequence of obvious retroviral origin, present as endogenous retroviruses (ERVs) within contemporary canids. In recent analyses of the canine reference genome, a few copies of ERVs were identified with features characteristic of recent integration, for example the presence of some ORFs and near-identical LTRs. Members of this group are referred to as CfERV-Fc1(a) and have been identified to have sequence similarity to the mammalian ERV-Fc/W groups. We have recently discovered and characterized a number of non-reference Fc1 copies in dogs and wild canids, and identified unexpectedly high levels of polymorphism among members of this ERV group. Some of the proviruses we have identified even possess complete or nearly intact open reading frames, identical LTRs, and derived phylogenetic clustering among other CfERV-Fc1(a) members. Based on LTR sequence divergence under an applied dog neutral mutation rate, it is thought these infections occurred within as recently as the last ~0.48 million years. There have been previous, but unsubstantiated, reports of reverse transcriptase activity as well as gamma-type C particles in tumor tissues of canines diagnosed with lymphoma.
    [Show full text]